Business   

Nicholas pact with Anna Varisty

CHENNAI: Nicholas Piramal India Limited (NPIL), has entered in to an agreement with the Centre Of Biotechnology (CBT) at Anna University in Chennai for exclusive R & D collaboration in the areas of cancer and inflammation. The agreement is designed to fast track the identification and development of plant extracts in the repository of CBT for the treatment of rheumatoid arthritis and cancer. Nicholas Piramal will have exclusive rights to commercialise any products coming out of this collaborative effort, says a company release. — Our Staff Correspondent

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Southern States | Other States | International | Opinion | Business | Sport | Miscellaneous |
Advts: Classifieds | Employment | Obituary |

Stories in this Section

• Industry grows at 6.5 p.c. in Sept.
• Branding India abroad
• Disinvestment options to meet revenue target
• CBI raids broker, SBI MF, UTI officials
• Two directors of Silverline resign
• Equities lose early gains
• ECB norms modified
• 3 held for taking bribes from IBM Corp.
• Rupee declines sharply
• Sterlite's call option in HZL
• Reliance becomes full-fledged cell operator
• OVL to continue as flagship overseas oil co.
• Nicholas pact with Anna Varisty
• Residency Hotels' plans
• Thinksoft bags SBI order
• Roadshows by Western Union, India Post
• Stanchart, Central Bank sign pact
• New COO for Optimus
• Novartis gets EMR approval for Glivec
• Essar gets LoI for ILD services
• Stock Market Index
• Exchange rates
• Bullion rates

Copyright © 2003, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu